News
Hosted on MSN4mon
BeiGene Secures FDA Approval for Stomach Cancer DrugTevimbra, or tislelizumab-jsgr, is approved as a first-line treatment for adults suffering from a certain type of unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma ...
The Business Research Company's Gastroesophageal Junction Adenocarcinoma Therapeutics Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 Market Reports Released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback